Targeting polyamines of parasitic protozoa in chemotherapy

Trends in Parasitology

Volumn 17, Issue 5, 2001, Pages 242-249

  Müller, Sylke ^a   Coombs, Graham H ^b   Walter, Rolf D ^c  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ANTITRYPANOSOMAL AGENT; PENTAMIDINE; POLYAMINE;

CHEMOTHERAPY; DRUG TARGETING; LEISHMANIA; MALARIA; NONHUMAN; POLYAMINE METABOLISM; REVIEW; TRYPANOSOMA; TRYPANOSOMIASIS; TURNOVER TIME;

ANIMALS; ANTIPROTOZOAL AGENTS; POLYAMINES; PROTOZOA; PROTOZOAN INFECTIONS;

PROTOZOA; TRYPANOSOMATIDAE;

EID: 0035017334     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4922(01)01908-0     Document Type: Review

References (61)

1. Polyamine metabolism as target for cancer chemoprevention
2. Population pharmacokinetics/toxicodynamics (PK/TD) relationship of SAM486A in phase I studies in patients with advanced cancers
3. 11-diethylnorspermine administered by multiple injection or continuous infusion
4. Regulation of cellular polyamines in mammals
5. Molecular genetics of polyamine synthesis in eukaryotic cells
6. Molecular mechanisms and therapeutic approaches to the treatment of African trypanosomiasis
7. Clinical aspects of inhibition of ornithine decarboxylase with emphasis on therapeutic trials of eflornithine (DFMO) in cancer and protozoan diseases
8. Measurement of the number of ornithine decarboxylase molecules in rat and mouse tissues under various physiological conditions by binding of radiolabelled α-difluoromethylornithine
9. Kinetics of S-adenosylmethionine cellular transport and protein methylation in T. brucei brucei and T. brucei rhodesiense
10. Polyamine metabolism in trypanosomes
11. Cloning and sequencing of the ornithine decarboxylase gene from T. brucei. Implications for enzyme turnover and selective difluoromethylornithine inhibition
12. Trypanosome ornithine decarboxylase is stable because it lacks sequences found in the carboxyl terminus of the mouse enzyme which target the latter for intracellular degradation
13. Amplification and molecular cloning of the ornithine decarboxylase gene of Leishmania donovani
14. Structural elements of ornithine decarboxylase required for intracellular degradation and polyamine-dependent regulation
15. Ornithine decarboxylase antizyme: a novel type of regulatory protein
16. Cloning of a trypanosomatid gene coding for an ornithine decarboxylase that is metabolically unstable even though it lacks the C-terminal degradation domain
17. Ornithine decarboxylase gene deletion mutants of Leishmania donovani
18. Procyclic T. brucei cell lines deficient in ornithine decarboxylase activity
19. Biochemical evidence for the presence of arginine decarboxylase activity in Trypanosoma cruzi
20. Diamine auxotrophy in a eukaryotic parasite
21. Regulation of a high-affinity diamine transport system in Trypanosoma cruzi epimastigotes
22. Trypanosoma cruzi has not lost its S-adenosylmethionine decarboxylase: characterization of the gene and the encoded enzyme
23. Trypanosoma cruzi epimastigotes lack ornithine decarboxylase but can express a foreign gene encoding this enzyme
24. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages
25. S-adenosylmethionine synthesis in Leishmania infantum promastigotes
26. Plasmodium berghei: Inhibition of the sporogonous cycle by α-difluoromethylornithine
27. Inhibitory action of α-difluoromethylornithine on rodent malaria (Plasmodium berghei)
28. Plasmodium berghei: Inhibitors of ornithine decarboxylase block exoerythrocytic schizogony
29. Plasmodium falciparum and Plasmodium berghei: Effects of ornithine decarboxylase inhibitors on erythrocytic schizogony
30. In the human malaria parasite Plasmodium falciparum, polyamines are synthesized by a bifunctional ornithine decarboxylase, S-adenosylmethionine decarboxylase
31. The ornithine decarboxylase domain of the bifunctional ornithine decarboxylase/S-adenosylmethionine decarboxylase of Plasmodium falciparum: Recombinant expression and catalytic properties of two different constructs
32. Polyamine biosynthesis in Cryptosporidium parvum and its implications for chemotherapy
33. Lysine-69 plays a key role in catalysis by ornithine decarboxylase through acceleration of the Schiff base formation, decarboxylation, and product release steps
34. X-ray structure of ornithine decarboxylase from T. brucei: the native structure and the structure in complex with α-difluoromethylornithine
35. Crystal structure of human ornithine decarboxylase at 2.1 Å resolution: structural insights to antizyme binding
36. Catalytic irreversible inhibition of Trypanosoma brucei brucei ornithine decarboxylase by substrate and product analogs and their effects on murine trypanosomiasis
37. Effects of the ornithine decarboxylase inhibitors dl-α-difluoromethylornithine and α-monofluoromethyldehydroornithine methyl ester alone and in combination with suramin against Trypanosoma brucei brucei central nervous system models
38. The crystal structure of human S-adenosylmethionine decarboxylase at 2.25 Å resolution reveals a novel fold
39. Synthesis of spermidine and norspermidine dimers as high affinity polyamine transport inhibitors
40. Polyamine transport systems of Leishmania donovani promastigotes
41. Putrescine and spermidine transport in Leishmania
42. Effect of polyamine depletion on macromolecular synthesis of the malarial parasite, Plasmodium falciparum, cultured in human erythrocytes
43. A kinetic characterization of putrescine and spermidine uptake and export in human erythrocytes
44. Arginine uptake by mouse erythrocytes infected with Plasmodium yoelii nigeriensis
45. Characterization of simian malarial parasite (Plasmodium knowlesi)-induced putrescine transport in rhesus monkey erythrocytes. A novel putrescine conjugate arrests in vitro growth of simian malarial parasite (Plasmodium knowlesi) and cures multidrug resistant murine malaria (Plasmodium yoelii) infection in vivo
46. 2-Substituted 3-(aminooxy)propanamines as inhibitors of ornithine decarboxylase. Synthesis and biological activity
47. In vivo trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors
48. Enzymes of parasite thiol metabolism as drug targets
49. Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress
50. Extrachromosomal homologous expression of trypanothione reductase and its complementary mRNA in Trypanosoma cruzi
51. Evidence that trypanothione reductase is an essential enzyme in Leishmania by targeted replacement of the tyrA gene locus
52. Nitrofuran drugs as common subversive substrates of Trypanosoma cruzi lipoamide dehydrogenase and trypanothione reductase
53. Parallel synthesis of a library of 1,4-naphthoquinones and automated screening of potential inhibitors of trypanothione reductase from Trypanosoma cruzi
54. New spermine and spermidine derivatives as potent inhibitors of Trypanosoma cruzi trypanothione reductase
55. Trypanothione reductase inhibition/trypanocidal activity relationships in a 1,4-bis(3-aminopropyl)piperazine series
56. Bis(7-amino-4-azaheptyl) dimethylsilane and bis(7-ethylamino-4-azaheptyl)dimethylsilane: inhibition of tumor cell growth in vitro and in vivo
57. Dimethylsilane polyamines: cytostatic compounds with potential as anticancer drugs
58. Bis(benzyl)polyamine analogs inhibit the growth of chloroquine-resistant human malaria parasites (Plasmodium falciparum) in vitro and in combination with α-difluoromethylornithine cure murine malaria
59. Translational regulation of ornithine decarboxylase and other enzymes of the polyamine pathway
60. Methionine recycling as a target for antiprotozoal drug development